US FDA Permits AliveCor's AI Mobile ECG To Measure QTc In COVID-19 Patients
Executive Summary
AliveCor wins US FDA permission to use its mobile ECG to detect heart problems caused by drugs to treat COVID-19 patients.
You may also be interested in...
ITC Ruling Hands AliveCor Big Win Against Tech Giant
A judge with the US International Trade Commission sided with AliveCor in its ongoing feud with Apple, finding that the tech giant infringed on AliveCor’s patented electrocardiogram technology. The initial ruling sets up a full ITC review later this year.
AliveCor Partners With SolveCare To Integrate ECGs Into Telehealth
AliveCor’s KardiaMobile EKG devices will be connected to SolveCare’s global telehealth exchange to allow users to share EKG data with their doctors through SolveCare’s blockchain platform.
Telehealth Sees Skyrocketing Demand Amid Regulatory Expansion, Hopes To Last Beyond COVID-19 Crisis
US telehealth companies are seeing skyrocketing demand for devices and services, which offers opportunities and challenges during this COVID-19 crisis.